Paul Hastings LLP, Private Equity: Buyouts & Venture Capital Investment (International Firms)

About

Provided by Paul Hastings LLP

Paul Hastings’ private equity practice has extensive experience in Asia, advising clients on a broad range of private equity and venture capital investment transactions. The team navigates structuring, negotiating, and implementing initial and later stage financings, restructurings and divestments, frequently in multi-jurisdictional settings involving complex and innovative structures.

Chambers Review

Provided by Chambers

Private Equity: Buyouts & Venture Capital Investment (International Firms) - China

Band 5

What the Team is Known For

Paul Hastings advises on private equity deals for a client roster featuring Chinese and international private equity houses and funds. The team remains highly focused on private equity investments in the real estate sector, with the capacity to advise throughout Asia. It has a strong track record of handling TMT-related transactions.

Notable practitioners

David Wang in Shanghai and Beijing is a key contact.

View ranking table

Work Highlights

Provided by Paul Hastings LLP

Paul Hastings advised GenScript Biotech and its subsidiary Probio Technology on Probio’s Series C financing, raising approximately USD224 million.

Strengths

Provided by Chambers

They are very commercial and take a balanced approach, providing creative solutions in addition to standard legal advice.